Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016–2018)
Harald Seifert, Joseph M. Blondeau, Kai Lucaßen, et al.
Journal of Global Antimicrobial Resistance (2022) Vol. 31, pp. 82-89
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Global Epidemiology and Mechanisms of Resistance of Acinetobacter baumannii-calcoaceticus Complex
Mariana Castanheira, Rodrigo E. Mendes, Ana Cristina Gales
Clinical Infectious Diseases (2023) Vol. 76, Iss. Supplement_2, pp. S166-S178
Open Access | Times Cited: 81
Navigating Available Treatment Options for Carbapenem-ResistantAcinetobacter baumannii-calcoaceticusComplex Infections
Ryan K. Shields, David L. Paterson, Pranita D. Tamma
Clinical Infectious Diseases (2023) Vol. 76, Iss. Supplement_2, pp. S179-S193
Open Access | Times Cited: 73
Current Therapeutic Approaches for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Infections
Petros I. Rafailidis, Periklis Panagopoulos, Christos Koutserimpas, et al.
Antibiotics (2024) Vol. 13, Iss. 3, pp. 261-261
Open Access | Times Cited: 14
Antibiotic Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections in View of the Newly Developed β-Lactams: A Narrative Review of the Existing Evidence
Francesca Serapide, Maurizio Guastalegname, Sara Palma Gullì, et al.
Antibiotics (2024) Vol. 13, Iss. 6, pp. 506-506
Open Access | Times Cited: 11
In Vitro Synergistic Activity of Antimicrobial Combinations against Carbapenem- and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae
Paraskevi Mantzana, Efthymia Protonotariou, Angeliki Kassomenaki, et al.
Antibiotics (2023) Vol. 12, Iss. 1, pp. 93-93
Open Access | Times Cited: 18
Treatment of infections caused by carbapenem-resistant Acinetobacter baumannii
Siqin Zhang, Lingfang Di, Qi Yan, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 6
Antibiotic Treatment of Carbapenem-Resistant <em>Acinetobacter baumannii </em>Infections in View of the Newly Developed β-Lactams: A Narrative Review of the Existing Evidence
Francesca Serapide, Maurizio Guastalegname, Sara Palma Gullì, et al.
(2024)
Open Access | Times Cited: 4
Complex Infection-Control Measures with Disinfectant Switch Help the Successful Early Control of Carbapenem-Resistant Acinetobacter baumannii Outbreak in Intensive Care Unit
József Kelemen, Marton Sztermen, Eva Krisztina Dakos, et al.
Antibiotics (2024) Vol. 13, Iss. 9, pp. 869-869
Open Access | Times Cited: 2
Geographical mapping and temporal trends of Acinetobacter baumannii carbapenem resistance: A comprehensive meta-analysis
Masoumeh Beig, Elnaz Parvizi, Tahereh Navidifar, et al.
PLoS ONE (2024) Vol. 19, Iss. 12, pp. e0311124-e0311124
Open Access | Times Cited: 2
Mortality Due to Multidrug-Resistant Gram-Negative Bacteremia in an Endemic Region: No Better Than a Toss of a Coin
Οlga Tsachouridou, Dimitrios Pilalas, Sideris Nanoudis, et al.
Microorganisms (2023) Vol. 11, Iss. 7, pp. 1711-1711
Open Access | Times Cited: 6
Prevalence of Acinetobacter baumannii and Candida auris in Patients Receiving Mechanical Ventilation
Anthony D. Harris, Lisa Pineles, J. Kristie Johnson, et al.
JAMA (2023) Vol. 330, Iss. 18, pp. 1769-1769
Open Access | Times Cited: 6
Geographical patterns of in vitro susceptibilities to tigecycline and colistin among worldwide isolates of Acinetobacter baumannii, Escherichia coli and Klebsiella pneumoniae: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2016–2021
Jiun‐Ling Wang, Chih‐Cheng Lai, Wen‐Chien Ko, et al.
International Journal of Antimicrobial Agents (2023) Vol. 62, Iss. 3, pp. 106930-106930
Closed Access | Times Cited: 5
A novel multivariate logistic model for predicting risk factors of failed treatment with carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia
Ke Sun, Fangchen Peng, Kaiqiang Xu, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 1
Optimizing Treatment for Carbapenem-Resistant Acinetobacter baumannii Complex Infections: A Review of Current Evidence
Seong Jin Choi, Eu Suk Kim
Infection and Chemotherapy (2024) Vol. 56, Iss. 2, pp. 171-171
Open Access | Times Cited: 1
In-vitro evaluation of different antimicrobial combinations with and without colistin against carbapenem-resistant Acinetobacter baumannii clinical isolates
Tuba Müderris, Gülden Dursun Manyaslı, Nurbanu Sezak, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 1
Risk factors and predictive model for nosocomial infections by extensively drug-resistant Acinetobacter baumannii
Jingchao Shi, Xiaoting Mao, Jianghao Cheng, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 1
Laboratory Surveillance of Acinetobacter spp. Bloodstream Infections in a Tertiary University Hospital during a 9-Year Period
Anastasia Spiliopoulou, Ioanna Giannopoulou, Stelios F. Assimakopoulos, et al.
Tropical Medicine and Infectious Disease (2023) Vol. 8, Iss. 11, pp. 503-503
Open Access | Times Cited: 4
Mortality Due to Multi-Drug Resistant Gram Negative Bacteremia in an Endemic Region: No Better than Toss a Coin
Οlga Tsachouridou, Dimitrios Pilalas, Sideris Nanoudis, et al.
(2023)
Open Access | Times Cited: 3
How to treat severe Acinetobacter baumannii infections
Emilio Bouza, Patricia Muñóz, Almudena Burillo
Current Opinion in Infectious Diseases (2023) Vol. 36, Iss. 6, pp. 596-608
Closed Access | Times Cited: 3
Acinetobacter baumannii - The Rise of a Resistant Pathogen

IntechOpen eBooks (2023)
Open Access | Times Cited: 3
Treatment of Acinetobacter baumannii
Anup Warrier, Sneha Radha
IntechOpen eBooks (2023)
Open Access | Times Cited: 2
In vitro killing of drug susceptible and multidrug resistant bacteria by amikacin considering pulmonary drug concentrations based on an inhaled formulation
Joseph M. Blondeau, Leah D. Blondeau, Shantelle D. Fitch
Journal of Chemotherapy (2024) Vol. 36, Iss. 5, pp. 389-397
Closed Access
Factors associated with antibiotic resistance and survival analysis of severe pneumonia patients infected with Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa: A retrospective cohort study in Jakarta, Indonesia
Gurmeet Singh, Tonny Loho, Mira Yulianti, et al.
SAGE Open Medicine (2024) Vol. 12
Open Access
Unraveling sulbactam-durlobactam: insights into its role in combating infections caused by acinetobacter baumannii
Yakun Fu, Tomefa E. Asempa, Joseph L. Kuti
Expert Review of Anti-infective Therapy (2024)
Closed Access
Carbapenem-resistant Acinetobacter baumannii in Latin America
Thiago Pavoni Gomes Chagas, Karyne Rangel, Salvatore G. De-Simone
IntechOpen eBooks (2024)
Open Access
Page 1 - Next Page

Scroll to top